Administer: Steady performance expected - Evli
Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier.
Administer is set to report Q3 results on November 5. We expect stable performance in line with H1 trends, with limited organic growth. Looking ahead, the Sarastia acquisitions remain a key catalyst for growth and earnings expansion.